Abstract
Tyrosylprotein sulfotransferase (TPST), the enzyme responsible for the sulfation of tyrosine residues, has been identified and characterized in submandibular salivary glands previously (William et al. Arch Biochem Biophys 338: 90-96). Tyrosylprotein sulfotransferase catalyses the sulfation of a variety of secretory and membrane proteins and is believed to be present only in the cell. In the present study, this enzyme was identified for the first time in human saliva. Analysis of human saliva and parotid saliva for the presence of tyrosylprotein sulfotransferase revealed tyrosine sulfating activity displayed by both whole saliva and parotid saliva at pH optimum of 6.8. In contrast to tyrosylprotein sulfotransferase isolated from submandibular salivary glands, salivary enzyme does not require the presence of Triton X-100, NaF and 5'AMP for maximal activity. Similar to the submandibular TPST, the enzyme from saliva also required MnCl2 for its activity. Maximum TPST activity was observed at 20mM MnCl2. The enzyme from saliva was immunoprecipitated and purified by immunoaffinity column using anti-TPST antibody. Affinity purified salivary TPST showed a single band of 50-54 kDa. This study is the first report characterizing a tyrosylprotein sulfotransferase in a secretory fluid.
Keywords: Tyrosylprotein sulfotransferase, human saliva, Purification, Affinity Chromatography, Anti- tyrosylprotein sulfotransferase antibody
1. Introduction
Tyrosine sulfation, a posttranslational modification involved in the processing of secretory proteins, is the covalent attachment of sulfate to the hydroxyl group of the tyrosyl residues in peptides and proteins. O-sulfation of the tyrosine residues has been the subject of several studies on the posttranslational modification of proteins 2. This modification occurs in the trans-Golgi, the compartment involved in the maturation and sorting of secretory proteins and peptides including cholecystokinin 3, fibrinopeptide B 4, gastrin 5 phyllokinin 6, leucosulfakinin 7, C4 complement 8, hirudin 9, P-selectin glycoprotein ligand-1 (PSGL-1) 10 and chemokine receptor CCR5 11. Tyrosine sulfation in these proteins has been suggested to be essential for their biological activity, half-life, and secretion. Sulfation of tyrosyl residues in cholecystokinin is required for its optimal biological activity 12 and in the case of hirudin, tyrosine sulfation increases the binding efficiency to thrombin 9. In M31 hybridoma cell line, tyrosine sulfation has been shown to serve as a signal for the secretion of IgG 13. In PSGL-1, tyrosine sulfation is required for its binding to p-selectin 10 and the tyrosine sulfation of CCR5 facilitates HIV-1 entry 11. Although the significance of tyrosine sulfation in these and several other proteins has been studied in detail, its role in salivary protein is yet to be investigated.
Tyrosylprotein sulfotransferase has been identified in numerous tissues including bovine adrenal medulla 14, rat liver 15, brain 16, gastric mucosa 17, submandibular salivary glands 18 and platelets 19. In this study, we demonstrate for the first time the detection, isolation and characterization of TPST from human saliva.
2. Materials and methods
Materials
[35S]PAPS (2 Ci/mmol) was from DuPont New England Nuclear, EAY (Mr 47 kDa), 5'-AMP were from Sigma-Aldrich. All other reagents were of analytical grade.
Collection of Saliva
Human Saliva
Unstimulated saliva was obtained from healthy individuals. The saliva was centrifuged at 6,000 RPM for 30 min and the clear supernatant was separated from sediment containing food particles.
Parotid Saliva
Parotid saliva was collected as described in 20. Parotid salivary flow was stimulated by means of confectionary which contained citric acid and tartaric acid. The saliva sample of about 10 ml was collected from parotid salivary glands by means of special devices. Protein concentration was estimated by the BCA protein assay reagent kit (Pierce chemical Co). Optimally diluted saliva samples were used for the tyrosylprotein sulfotransferase activity.
Assay of tyrosylprotein sulfotransferase
The tyrosylprotein sulfotransferase assay mixture contained the following components: acceptor, unsulfated EAY at concentrations indicated in text, 5 µM [35S]PAPS (400,000 cpm), 20 mM MnCl2, 20 mM MES buffer pH 6.8 and saliva (50 μg protein) in a final volume of 50 µl. Assays were initiated by the addition of the enzyme and incubated for 30 min at 37°C. The reactions were stopped by spotting 35 µl aliquot of the reaction mixture on a 2.4 x 2.4 cm Whatman No. 3MM filter paper 15. The papers were washed three times for 15 min in 10% trichloroacetic acid/10 mM Na2SO4 and rinsed 5 min in 95% ethanol. The dried papers were placed in vials containing scintillation solution and counted in a TriCarb-1500 scintillation counter.
SDS-Polyacrylamide Gel Electrophoresis
Proteins were separated by electrophoresis by the method of Laemml 21. The separating gels contained 10% (w/v) acrylamide, bis(acrylamide) in the ratio of 37.5:1, 0.375 M Tris-HCl, pH 8.8, 0.1% SDS, 0.026% TEMED, and 0.026% ammonium persulfate. The stacking gel contained 3% acrylamide, bis(acrylamide) in the same ratio as before, 0.125 M Tris-HCl, pH 6.8, 0.1% SDS, 0.05% ammonium persulfate, and 0.4% TEMED. Electrophoresis was performed in a Mighty Small gel apparatus (Hoefer Scientific Instruments, San Francisco, CA) at 4°C at a constant current of 20 mA per gel for approximately 1 h. Protein bands on the gels were visualized by silver staining.
Immunoblot Procedure
Proteins were resolved by SDS-PAGE on a 10% polyacrylamide gel and electrophoretically transferred (20 V for 20 min) to a nitrocellulose membrane (Millipore) by means of a Bio-Rad Semi Dry Transblot apparatus according to the procedure supplied by the Bio-Rad. The section of the nitrocellulose membrane containing the molecular weight standards was cut off and stained with Ponceau S in 45% methanol and 10% acetic acid and destained in water. The membrane was blocked overnight at 4°C with bovine serum albumin (3% w/v). The blot was washed with Tris buffered saline (25 mM, pH 8.0) containing 0.05% Tween 20 and 0.1% BSA and incubated with IgG fraction of rabbit anti TPST antibody for an hour at room temperature. After washing the blot with wash buffer, the membrane was further incubated with alkaline phosphatase conjugated goat anti-rabbit immunoglobulin G (1:5000) for an hour. The substrate for alkaline phosphatase was consisted of the p-nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.
Immunoprecipitation
Immunoprecipitation of the TPST present in saliva was carried out in 1.5 ml microcentrifuge tubes using TPST antibody, as described in 1. Briefly, different concentrations of immune and preimmune sera (1:1000 dilution) were added to 100 µl of saliva and the mixture was incubated at room temperature for 4 h. After incubation, 30 µl of Protein A sepharose (25%) was added. Following overnight agitation at 4°C, Protein A sepharose beads bound to antigen-antibody complexes were pelleted by centrifugation and the supernatant was used for TPST assay.
Purification of tyrosylprotein Sulfotransferase from saliva by Immuno affinity Chromatography
The IgG fraction of rabbit anti-TPST was coupled to CNBr-activated Sepharose 4B beads. About 75 mg of IgG fraction was coupled to 7.5 ml CNBr-Sepharose 4B as described earlier 22 and the beads were stored at 4oC with addition of preservative. The amount of protein coupled to beads was measured by estimating protein in the supernatant before and after coupling. Two ml beads were packed in a mini column and equilibrated with 20 mM MES pH 6.8. Five ml volumes of saliva was applied to the affinity column and equilibrated for 30 min. The column was washed with 10 volumes of equilibration buffer. The bound enzyme was eluted with Gly-HCl buffer pH 2.7 and pH was raised immediately with 1.0 M Tris. The fractions were further tested for the presence of enzyme by dot blotting. The enzyme activity was assayed and the purity of the enzyme was examined staining the polyacrylamide gels with silver.
3. Results
Characterization of TPST
The presence of tyrosylprotein sulfotransferase activity was observed in human saliva using EAY as sulfate acceptor and [35S] PAPS as sulfate donor. The clear supernatant of normal and parotid saliva showed TPST activity. The tyrosine sulfation increased proportionately with increasing concentrations of saliva protein up to 25 µg (Figure 1). The enzyme activity increased with increased incubation time up to 30 min and reached its maximum at 60 min (Figure 2). The effect of pH on the EAY sulfation by human whole saliva and parotid saliva are shown in Figure 3. Using the MES buffer, the pH optimum for the sulfation of EAY by the two enzymes was found to be 6.8 and significant activity was also observed in parotid saliva at pH 5.5. In the absence of MnCl2, minimal sulfation of EAY was detected. Optimum enzyme activity was detected at 20 mM MnCl2 (Figure 4)
The direct effect of increasing concentrations (0.025%-0.25%) of Triton X-100 concentrations on the activity of tyrosylprotein sulfotransferase was studied. No change in the enzyme activity was observed at various concentrations of Triton X-100 (data not shown). Since the enzyme present in saliva was not membrane bound, tyrosylprotein sulfotransferase sulfation of EAY was not altered in the presence of detergent. Requirements of metal ions for tyrosylprotein sulfotransferase of human whole saliva is given in Table 1. Of the metals examined at 20 mM, Mn2+ and Ca2 were able to stimulate tyrosylprotein sulfotransferase activity, where as Mg2+ exhibited around 50% of the stimulation attained with Mn2+ and EDTA inhibited the enzyme activity.
Table 1.
Divalent cation 10 (mM) | Tyrosylprotein Sulfotransferase (pmol/mg/30 min) |
---|---|
MnCl2 | 12.4 ± 1.7 |
CaCl2 | 9.7 ± 1.4 |
MgCl2 | 5.6 ± 1.3 |
EDTA | 1.9 ± 0.7 |
Enzyme activities were measured as described under Materials and Methods. Values are the mean ± SE of three experiments
Immunoprecipitation
The polyclonal TPST antibodies were also tested for their ability to immunoprecipitate the TPST in the saliva. Antibodies were incubated with the saliva and coupled to protein A Sepharose beads. After centrifugation, presence of the TPST activity was determined in the supernatant by enzyme assay. As shown in Figure 5, with increasing concentration of TPST antiserum in the immunoprecipitated sample, the supernatant showed decreased TPST activity. Almost 80% of the activity was immunoprecipitated with 50 µl of a 1:1000 dilution of antiserum, when compared with the preimmune serum.
Purification of TPST from Human saliva
Purification of TPST to homogeneity from saliva was achieved by immunoaffinity column chromatography. This method resulted in a 25, 071-fold increase in tyrosine sulfating activity (Table 2). The purified enzyme exhibited protein band of 50-54 kDa on SDS-PAGE (Figure 6A) and on immunoblots (Figure 6B) similar to the enzyme obtained from submandibular salivary glands 1. The 3, 389-fold purification of tyrosine sulfating activity from human saliva to near homogeneity (Table 2) differs from the 140, 000 and 25, 358-fold purification required for adrenal and rat submandibular salivary gland enzyme, respectively, suggesting that saliva represent a better enriched source of this enzyme.
Table 2.
Property | Submandiblular salivary gland TPST | Saliva TPST |
---|---|---|
Mol. Wt (kDa) | 55 | 55 |
pH optimum | 6.2-6.8 | 6.8 |
Additives: MnCl2 (mM) Triton X-100 | 20 Increase in activity | 20 No increase in activity |
Spec. Activity* of unpurified TPST | 2.1 | 12.3 |
Spec. Activity* of purified TPST | 53250 | 41670 |
Purification fold | 25358 | 3389 |
* (pmol/mg/30 min)
4. Discussion
Sulfation represents an important mechanism in vivo for the biotransformation and excretion of a variety of proteins. Upon sulfation some proteins undergo changes in their biological activities to fulfill particular biochemical and physiological needs. Since the first description of a TPST activity, the enzyme has been reported in various tissues in bovine adrenal medulla 14, rat 15, and PC12 cells 23. However, there are no reports of its presence in secretion. In this paper, the existence of tyrosylprotein sulfotransferase activity was demonstrated in human whole saliva and parotid saliva using 35S-PAPS as co-substrate for sulfation. Using the acidic, synthetic polymer, poly Glu6, Ala3, Tyr1 (EAY), Domiano and Roth 15 demonstrated a fairly wide-tissue distribution of tyrosylprotein sulfotransferase in the rat. Later, Sundaram 18 have characterized the enzyme present in the rat submandibular salivary glands. Some of the properties of human salivary tyrosylprotein sulfotransferase described here appear to be similar to those reported earlier for this enzyme in other rat tissues. As shown in the Figure 4, the human salivary tyrosylprotein sulfotransferase exhibited optimum pH at 6.8, which is similar to sulfotransferase reported in rat submandibular salivary glands 18 and other rat tissues 15,17. However, the enzyme isolated from rat submandibular salivary glands displayed pH optimum of 6.2 18 and the pH optimum observed for rat brain was 5.8 24. The solubilized enzyme from adrenal medulla has a pH optimum between 6.0 and 6.5 14. Human salivary tyrosylprotein sulfotranferase activity was stimulated by the divalent cations Mn2+, Ca2+ and partially by Mg2+ and was inhibited by EDTA. The enzymatic activity mediating the sulfation of proteins in PC12 cell was stimulated by the presence of Mg2+ and Mn2+ and inhibited by EDTA 14. Both Mn2+ and Mg2+ were equally effective in activating EAY sulfation by bovine adrenal medulla 14 and rat cerebral cortex 16, where as Mn2+ and Co2+ stimulated rat liver tyrosylprotein sulfotrasferase 15. In contrast, sulfation of an endogenous membrane protein in A431 cell was not inhibited by EDTA 25.
Antibodies raised against the tyrosylprotein sulfotransferase from rat submandibular salivary glands recognized the enzyme present in the saliva and the antibody was also capable of immunoprecipitating the enzyme activity in saliva. SDS-PAGE analysis of salivary tyrosylprotein sulfotransferase isolated from antibody column revealed a protein of 50-54 kDa in silver stained gels. A similar 50-54 kDa protein was observed for TPST purified from bovine adrenal medulla 26, rat liver 22 and submandibular salivary glands 1.
5. Summary
We have identified TPST in human saliva in addition to our earlier reports on its presence in submandibular salivary glands 1. Although the enzyme activity responsible for tyrosine sulfation was demonstrated several decades ago, very little is known about the function of tyrosine sulfation, particularly, in salivary metabolism. The better understanding of this process needs further studies involving the identification of salivary proteins that are candidates for tyrosine sulfation. In naturally occurring substrates of tyrosylprotein sulfotransferase, the sulfated tyrosyl residues are predominantly surrounded by acidic amino acids 27,28. These studies suggest that acidic environments are the important determinants for tyrosine sulfation. Salivary statherin is a 43-residue polypeptide which is tyrosine-rich and contains 7 tyrosine residues. The peptide also contains a sequence E-Q-P-L-Y (residues 26-30) suggested for tyrosine sulfation 28,29. The availability of TPST and antibody will facilitate well-defined studies on the role of this important function in saliva in physiological and pathological conditions.
Acknowledgments
This work was supported by grant #AA09191 from the National Institute on Alcohol Abuse and Alcoholism.
References
- 1.William S, Ramaprasad P, Kasinathan C. Purification of tyrosylprotein sulfotransferase from rat submandibular salivary glands. Arch Biochem Biophys. 1997;338:90–96. doi: 10.1006/abbi.1996.9800. [DOI] [PubMed] [Google Scholar]
- 2.Huttner WB, Baeuerle PA. Protein Sulfation on Tyrosine. Modern Cell Biology. 1988;6:97–140. [Google Scholar]
- 3.Mutt V. Cholecystokinin-isolation, structure and functions. In: Glass GBJ, editor. Gastrointestinal Hormones. New York: Raven Press; 1980. p. 169. [Google Scholar]
- 4.Bettelheim FR. Tyrosine-O-sulphation in a peptide from fibrinogen. J Am Chem Soc. 1954;76:2838– 22839. [Google Scholar]
- 5.Gregory H, Hardy P.M, Jones D.S. et al. The antral hormone gastrin. Nature. 1964;204:931–933. doi: 10.1038/204931a0. [DOI] [PubMed] [Google Scholar]
- 6.Anastasi A, Bertaccini G, Erspamer V. Pharmacological data on phyllokinin (bradykinyll-isoleucyl-tyrosine-O-sulphate) and bradykinyl-isoleucy-tyrosine. J Pharmacol Chemother. 1966;27:479–485. doi: 10.1111/j.1476-5381.1966.tb01859.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nachman R.J, Holman G.M, Cook B.J. et al. Leukosulfakinin-II, a blocked sulfated insect neuropeptide with homology to cholecystokinin and gastrin. Biochem Biophys Res commun. 1986;140:357–364. doi: 10.1016/0006-291x(86)91098-3. [DOI] [PubMed] [Google Scholar]
- 8.Hortin G.L, Farries T, Atkinson J.P. Sulfation of C4 (fourth component of complement): effects of C4 processing and activity. FASEB J. 1988;2:A1646. [Google Scholar]
- 9.Stone S.R, Hofsteenge J. Kinetics of the inhibition of thrombin by Hirudin. Biochemistry. 1986;25:4622–4628. doi: 10.1021/bi00364a025. [DOI] [PubMed] [Google Scholar]
- 10.Hirata T, Furukawa Y, Yang B.G. et al. Human P-selectin glycoprotein ligand-1 (PSGL-1) interacts with the skin-associated chemokine CCL27 via sulfated tyrosines at the PSGL-1 amino terminus. J Biol Chem. 2004;279:51775–1782. doi: 10.1074/jbc.M409868200. [DOI] [PubMed] [Google Scholar]
- 11.Farzan M, Mirzabekov T, Kolchinsky P. et al. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell. 1999;96:667–676. doi: 10.1016/s0092-8674(00)80577-2. [DOI] [PubMed] [Google Scholar]
- 12.Bodanszky M, Martinez J, Priestley G.P. et al. Cholecystokinin (pancreozymin) 4 Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate. J Med Chem. 1978;21:1030–1035. doi: 10.1021/jm00208a006. [DOI] [PubMed] [Google Scholar]
- 13.Baeuerle P.A, Huttner W.B. Inhibition of N-glycosylation induces tyrosine sulfation of hybridoma immunoglobuin G. EMBO J. 1984;3:2209–2215. doi: 10.1002/j.1460-2075.1984.tb02118.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lee R.W.H, Huttner W.B. (Glu62, Ala30, Tyr8)n serves as high-affinity substrate for tyrosylprotein sulfotransferase: A Golgi enzyme. Proc Natl Acad Sci. 1985;82:6143–6147. doi: 10.1073/pnas.82.18.6143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Domiano S.R, Roth J.A. Characterization of Tyrosylprotein Sufotransferase from Rat Liver and Other Tissues. J Biol Chem. 1989;264:899–905. [PubMed] [Google Scholar]
- 16.Vargas F, Schwartz J.C. Apparent identity of cerebral tyrosylsulfo-transferase activities using either a cholecystokinin derivative or an acidic amino acid polymer as substrate. FEBS LETTERS. 1987;211:234–238. doi: 10.1016/0014-5793(87)81443-6. [DOI] [PubMed] [Google Scholar]
- 17.Kasinathan C, Sundaram P, Slomiany B.L. et al. Identification of tyrosylprotein sulfotransferase in rat gastric mucosa. Enzyme. 1992;46:179–187. doi: 10.1159/000468786. [DOI] [PubMed] [Google Scholar]
- 18.Sundaram P, Slomiany A, Slomiany B.L. et al. Tyrosylprotein sulfotransferase in rat submandibular salivary glands. Int J Biochem. 1992;24:663–667. doi: 10.1016/0020-711x(92)90344-z. [DOI] [PubMed] [Google Scholar]
- 19.Sane DC, Baker MS. Human platelets possess tyrosylprotein sulfotransferase (TPST) activity. Thromb Haemost. 1993;69:272–275. [PubMed] [Google Scholar]
- 20.Hay D.I. Fractionation of human parotid salivary proteins and the isolation of an histidine-rich acidic peptide which shows high affinity for hydroxyapatite surfaces. Arch Oral Biol. 1975;9:553–558. doi: 10.1016/0003-9969(75)90073-4. [DOI] [PubMed] [Google Scholar]
- 21.Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- 22.Ramaprasad P, Kasinathan C. Isolation of tyrosylprotein sulfotransferase from liver. Gen Pharmacol. 1998;30:555–559. doi: 10.1016/s0306-3623(97)00304-2. [DOI] [PubMed] [Google Scholar]
- 23.Lee R.W.H, Huttner W.B. Tyrosine-O-sulfated proteins of PC12 pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase. J Biol Chem. 1983;258:11326–11334. [PubMed] [Google Scholar]
- 24.Vargas F, Frerot O, Tuong M.D. et al. Characterization of a tyrosine sulfotransferase in rat brain using cholecystokinin derivatives as acceptors. Biochemistry. 1985;24:5938–5943. doi: 10.1021/bi00342a037. [DOI] [PubMed] [Google Scholar]
- 25.Liu N, Baenziger J.U. In vivo and in vitro tyrosine sulfation of a membrane glycoprotein. J Biol Chem. 1986;261:856– 861. [PubMed] [Google Scholar]
- 26.Niehrs C, Huttner W.B. Purification and characterization of tyrosylprotein sulfotransferase. EMBO J. 1990;9:35–42. doi: 10.1002/j.1460-2075.1990.tb08077.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hortin G, Tollefsen D.M, Strauss A.W. Identification of two sites of sulfation of human heparin cofactor II. J Biol Chem. 1986;261:15827– 15830. [PubMed] [Google Scholar]
- 28.Lin W.H, Larsen K, Hortin G.L. et al. Recognition of substrates by tyrosylprotein sulfotransferase. Determination of affinity by acidic amino acids near the target sites. J Biol Chem. 1992;267:2876–2879. [PubMed] [Google Scholar]
- 29.Bundgaard J.R, Vuust J, Rehfeld J.F. New consensus features for tyrosine O-sulfation determined by mutational analysis. J Biol Chem. 1997;272:21700–21705. doi: 10.1074/jbc.272.35.21700. [DOI] [PubMed] [Google Scholar]